TET2 and chronic myelogenous leukemia, BCR-ABL1 positive: NGS analysis with the myeloid panel was repeated, confirming the persistence of mutations in DNMT3A and TET2 observed at the diagnosis of CML, with similar VAF, without additional abnormalities.